EOSE
Eos Energy Enterprises, Inc.
There isn't enough reported data to score EOSE yet.
HON
Honeywell International Inc.
HON's fundamentals are weak: revenue fell 17% and its operating margin fell 3 points to 19%. Its PE of 10x looks cheaper than it really is, because one-off gains boosted its recent earnings. Analysts expect earnings to hold roughly steady.
EOSE Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
EOSE's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
HON Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Healthy | |
| Stable | |
| Healthy |
HON's profitability and balance sheet are currently healthy, and its cash flow is stable, but its revenue is weak.
EOSE PE Valuation
EOSE has no meaningful PE right now: it lost money over the past year.
HON PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $223 | — |
| Cheap | 20x | $438 | +96% |
| Fair | 23x | $515 | +130% |
| Forward | 24x | $223 | — |
| Expensive | 28x | $628 | +181% |
Historical ranges are pointers, not guarantees.
HON's PE is in its cheap range at 10x, but its recent earnings include one-off gains. On analysts' estimates for next year's earnings, today's price would be 24x, in its fair range.
EOSE Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect EOSE's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HON Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Strong decline | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HON's profitability to improve, but its revenue to decline.
EOSE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$2.69 | +$0.85 |
| Q2 2023 | -$3.76 | -$1.00 |
| Q1 2023 | -$3.65 | -$0.86 |
| Q4 2022 | -$3.68 | -$1.32 |
| Q3 2022 | -$3.54 | +$5.19 |
HON has the stronger earnings trend. Trailing diluted EPS is down 224% for EOSE versus HON up 17%.
HON Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.49 | -57% |
| Q3 2026 | $22.13 | +17% |
| Q2 2026 | $25.77 | +47% |
| Q1 2026 | $12.84 | -26% |
| Q4 2025 | $14.70 | -16% |
| Q3 2025 | $18.98 | +9.6% |
| Q2 2025 | $17.58 | +0.2% |
| Q1 2025 | $17.40 | +0.8% |
| Q4 2024 | $17.42 | +2.8% |
HON earned $22.13 per share over the past year, up 17% from the year before. Its recent earnings include one-off gains.
EOSE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $82.7M | +171% |
| Q2 2026 | $68.8M | +351% |
| Q1 2026 | $57M | +445% |
| Q4 2025 | $58M | +700% |
| Q3 2025 | $30.5M | +3473% |
| Q2 2025 | $15.2M | +1597% |
| Q1 2025 | $10.5M | +58% |
| Q4 2024 | $7.3M | +9.7% |
EOSE has the edge over HON on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -96% | +105 points |
| Q2 2026 | -122% | +297 points |
| Q1 2026 | -139% | +367 points |
| Q4 2025 | -140% | +573 points |
| Q3 2025 | -201% | +6044 points |
| Q2 2025 | -419% | +2815 points |
| Q1 2025 | -506% | +117 points |
| Q4 2024 | -713% | -74 points |
EOSE's operating margin was −96% last quarter, up 105 points from the same quarter a year ago, near the top of its range since 2019.
HON Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $5B | -52% |
| Q2 2026 | $9.7B | -6.1% |
| Q1 2026 | $9.1B | -6.9% |
| Q4 2025 | $9.8B | -3.3% |
| Q3 2025 | $10.4B | +7% |
| Q2 2025 | $10.4B | +8.1% |
| Q1 2025 | $9.8B | +7.9% |
| Q4 2024 | $10.1B | +6.9% |
HON's revenue has slid since its 2025 peak: $5B last quarter, down 52% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 21% | -1.9 points |
| Q2 2026 | 23% | +0.2 points |
| Q1 2026 | 23% | +0.3 points |
| Q4 2025 | 11% | -9.7 points |
| Q3 2025 | 23% | -0.5 points |
| Q2 2025 | 23% | -0.1 points |
| Q1 2025 | 23% | +0.8 points |
| Q4 2024 | 21% | +5 points |
HON has the edge over EOSE on profitability, with a higher operating margin.
EOSE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$105.1M | -$22.4M |
| Q2 2026 | -$107.4M | -$34.3M |
| Q1 2026 | -$154.8M | -$121M |
| Q4 2025 | -$75.2M | -$19.5M |
| Q3 2025 | -$82.7M | -$28.5M |
| Q2 2025 | -$73.2M | -$40.6M |
| Q1 2025 | -$33.8M | +$10.7M |
| Q4 2024 | -$55.8M | -$10.2M |
EOSE has burned cash in almost every quarter: −$443M over the past year, against −$246M the year before.
HON Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $286M | -90% |
| Q2 2026 | $961M | -5.4% |
| Q1 2026 | -$873M | -352% |
| Q4 2025 | $1.1B | -39% |
| Q3 2025 | $2.9B | +70% |
| Q2 2025 | $1B | -8.6% |
| Q1 2025 | $346M | +61% |
| Q4 2024 | $1.9B | -27% |
HON has the edge over EOSE on cash generation, producing positive trailing cash flow while its opponent burns cash.
EOSE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +63% | +213M shares |
| 1 year | +161% | +341M shares |
| 3 years | +888% | +497M shares |
EOSE has 553M diluted shares, up 161% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
HON Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +600K shares |
| 1 year | -0.1% | -200K shares |
| 3 years | -4.3% | -14.3M shares |
| 5 years | -8.7% | -30.3M shares |
| Available history | -13% | -46M shares |
HON has the edge over EOSE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | $1B |
| Q4 2025 | $100M |
| Q3 2025 | $100M |
| Q2 2025 | $1.7B |
| Q1 2025 | $1.9B |
| Q4 2024 | $455M |
HON spent $1.1B buying back its own shares over the past year, down 74% from the year before.
EOSE Net Leverage
EOSE's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HON Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.4x | Healthy |
| Q2 2026 | 2.8x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 2.3x | Moderate |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 2.3x | Moderate |
| Q4 2024 | 2.1x | Moderate |
HON's net debt is about 1.4 years of its operating earnings (EBITDA), down from 2.3 years a year ago.
EOSE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.5 | Neutral |
| Stochastic | 7.4 | Oversold |
EOSE's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
HON Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.9 | Neutral |
| Stochastic | 45.0 | Neutral |
HON's weekly RSI is 52 (neutral) and its Stochastic is 45 (neutral).
EOSE PE vs Industrials Sector
EOSE has no meaningful PE right now: it lost money over the past year.
HON PE vs Industrials Sector
| Metric | HON | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 24x | 58% below |
| PE % | 4 | 58 | 54 pts below |
HON is trading at 10x earnings, a 58% discount to the Industrials sector's median of 24x, though its recent earnings include one-off gains.
EOSE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.24 | 19% below |
| 20 week MA | $3.28 | 45% below |
| 50 week MA | $7.01 | 74% below |
| 100 week MA | $7.10 | 75% below |
| 200 week MA | $4.53 | 60% below |
EOSE is in a downtrend: it's below all five of its weekly moving averages, and 60% below its 200-week average.
HON Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $216.1 | 3.4% above |
| 20 week MA | $221.4 | 0.9% above |
| 50 week MA | $223.8 | 0.1% below |
| 100 week MA | $215.2 | 3.9% above |
| 200 week MA | $203.7 | 9.7% above |
HON has the edge over EOSE on trend strength, trading above more of its moving averages.
EOSE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.72 | $19.2 | +98% |
| 2021 | $19.2 | $8.57 | -55% |
| 2022 | $8.57 | $1.08 | -87% |
| 2023 | $1.08 | $1.09 | +0.9% |
| 2024 | $1.09 | $5.17 | +374% |
| 2025 | $5.17 | $11.9 | +129% |
| 2026 YTD | $11.9 | $1.81 | -85% |
EOSE's yearly returns have swung widely, from +374% in 2024 to −87% in 2022. It's down 85% so far in 2026.
HON Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $169.2 | $200.8 | +19% |
| 2021 | $200.8 | $196.7 | -2.1% |
| 2022 | $196.7 | $205.0 | +4.2% |
| 2023 | $205.0 | $201.0 | -1.9% |
| 2024 | $201.0 | $220.0 | +9.4% |
| 2025 | $220.0 | $200.7 | -8.8% |
| 2026 YTD | $200.7 | $223.5 | +11% |
HON has the edge over EOSE on returns for 2026, with the stronger performance.